]>
IRCT20210630051749N1 IRCT 2021-07-05 Mashhad University of Medical Sciences The effect of oral use of Mentha Longifolia capsule on the symptoms of premenstrual and the severity and duration of menstrual pain The effect of oral use of Mentha Longifolia capsule on the symptoms of premenstrual syndrome and primary dysmenorrhea 2021-07-11 anticipated 64 Complete https://irct.ir/trial/57247 interventional Randomization: Randomized, Blinding: Triple blinded, Placebo: Used, Assignment: Parallel, Purpose: Treatment, Randomization description: The research units are easily selected and divided into two groups receiving mint capsules and placebo by random allocation of block type and using PASS software. The drug concealment method is coded in the same package in terms of shape and design, Blinding description: Researchers, participants, and the Data Safety and Supervision Committee will keep blind in this study. They will have no information about the attribution of individuals to groups. 3 Condition 1: primary dysmenorrhea. Condition 2: Premenstrual syndrome. Intervention 1: Intervention group: In the intervention group, mint oral capsule will be used once a day from 7 days before the start of menstruation until the first 3 days of menstruation. Intervention 2: Control group: In the control group, mint oral capsule will be used once a day from 7 days before the start of menstruation until the first 3 days of menstruation. Undecided - It is not yet known if there will be a plan to make this available Justification or reason for indecision in sharing IPD is There is no more information
public Samira Ebrahimzadehzagami
Razavi Khorasan Province, Mashhad, Daneshgah Avenue
Mashhad Iran (Islamic Republic of) 9137913199 +98 51 3859 1511 EbrahimzadehzagamiS@mums.ac.ir Mashhad University of Medical Sciences scientific Samira Ebrahimzadehzagami
Razavi Khorasan Province, Mashhad, Daneshgah Avenue
Mashhad Iran (Islamic Republic of) 9137913199 +98 51 3859 1511 EbrahimzadehzagamiS@mums.ac.ir Mashhad University of Medical Sciences Iran (Islamic Republic of) Be Iranian and single. Be a resident of the dormitories of Mashhad University of Medical Sciences. Have regular menstruation Have premenstrual syndrome and primary dysmenorrhea at the same time. Be 18-35 years old. No medication No allergies to mint No alcohol or drugs or tobacco No diet No disease 18 years 35 years Female Discontinuation of medication or irregular use of medication (not taking medication twice or more) Have a BMI of more than 30. Be a professional athlete. Suffer from depression, stress and anxiety . Experience an unfortunate or stressful event while studying. Has used traditional medicine methods to reduce symptoms and improve pain. Married while studying. N94.4 R10.3 Primary Dysmenorrhea Pain localized to other parts of lower abdomen Treatment - Drugs Placebo Intervention group: In the intervention group, mint oral capsule will be used once a day from 7 days before the start of menstruation until the first 3 days of menstruation. Control group: In the control group, mint oral capsule will be used once a day from 7 days before the start of menstruation until the first 3 days of menstruation. Mean score of total premenstrual syndrome symptoms, severity and duration of dysmenorrhea. Timepoint: Mean score of total symptoms of premenstrual syndrome, severity and duration of dysmenorrhea at the beginning of the study (before the intervention) and 1 and 2 months after the intervention. Method of measurement: The mean total score of premenstrual syndrome symptoms will be assessed by COPE premenstrual events calendar form and the severity and duration of dysmenorrhea in the first and second months of the treatment cycle, by visual pain scale and COX scale and by patients' self-report. Mashhad University of Medical Sciences Approved 2021-06-30 Ethics Committee of Mashhad University of Medical Sciences Khorasan Razavi, Mashhad, Daneshgah St., Ph.D. Crossroads, Ibn Sina St., School of Nursing and Midwifery مشهد Razavi Khorasan Iran (Islamic Republic of)